The human low affinity receptors for the Fc domain ofimmunoglobulin G, Fc~/RIII, are encoded by two genes (IliA and IIIB) which share >95% sequence identity in both coding and flanking sequences. Despite this extraordinary sequence conservation, IliA is expressed in natural killer (NK) cells and macrophages and is absent in neutrophils, whereas IIIB is expressed only in neutrophils. To determine the molecular basis for this differential expression, we have generated transgenic mice using the genomic sequences of IliA and IIIB. IliA and IIIB transgenic mice show faithful reconstitution of this human pattern of cell type specificity. To determine the cis acting sequence elements that confer this specificity, we constructed chimeric genes in which 5.8 kb of 5' sequences of the IIIB gene has been replaced with a homologous region from the IliA gene, and conversely, IliA 5' sequences have been substituted for the analogous region of the IIIB gene. Promoter swap transgenic mice that carry IliA 5' flanking sequences express Fc~/tklII in macrophages and NK cells. In contrast, promoter swap transgenic mice that contain 11113 5' sequences express Fc~/RIII in neutrophils only. These studies define the elements conferring the cell type-specific expression of the human Fc~/RIII genes within the 5' flanking sequences and first intron of the human FcyRIIIA and Fc~RIIIB genes.
Summary
The human low affinity receptors for the Fc domain ofimmunoglobulin G, Fc~/RIII, are encoded by two genes (IliA and IIIB) which share >95% sequence identity in both coding and flanking sequences. Despite this extraordinary sequence conservation, IliA is expressed in natural killer (NK) cells and macrophages and is absent in neutrophils, whereas IIIB is expressed only in neutrophils. To determine the molecular basis for this differential expression, we have generated transgenic mice using the genomic sequences of IliA and IIIB. IliA and IIIB transgenic mice show faithful reconstitution of this human pattern of cell type specificity. To determine the cis acting sequence elements that confer this specificity, we constructed chimeric genes in which 5.8 kb of 5' sequences of the IIIB gene has been replaced with a homologous region from the IliA gene, and conversely, IliA 5' sequences have been substituted for the analogous region of the IIIB gene. Promoter swap transgenic mice that carry IliA 5' flanking sequences express Fc~/tklII in macrophages and NK cells. In contrast, promoter swap transgenic mice that contain 11113 5' sequences express Fc~/RIII in neutrophils only. These studies define the elements conferring the cell type-specific expression of the human Fc~/RIII genes within the 5' flanking sequences and first intron of the human FcyRIIIA and Fc~RIIIB genes.
R
eceptors for the Fc domain oflgG, Fc'yRs, are a family of oligomeric cell surface glycoproteins expressed on effector and lymphoid cells that mediate a variety of activation and inhibitory responses to antigen-antibody complexes. Three classes of Fc~/Rs have been defined based on their different molecular mass, affinity for IgG, and genomic structures: the high affinity Fc~/RI, and the low affinity Fc~/RII and Fc~/RIII (1, 2) . In humans, Fo/RIII exists in two alternative forms. FcyRIIIA is a heteromultimeric complex composed ofa ligand-binding ot chain and dimeric ~/ or ~ chains (3) (4) (5) . The c~ chain, encoded by the Fc~/RIIIA gene, is a type I transmembrane protein that contains the extracellular ligand-binding domain and a distinct cytoplasmic domain (6) . The ~/and { chains are required for assembly and signal transduction of the receptor complex (5). In contrast, Fc~/RIIIB is a monomeric protein anchored to the outer leaf of the plasma membrane by a glycosyl phosphatidyl inositol moiety (7, 8) . The ot chains oflIIA and IIIB are >95% identical, conferring indistiguishable ligand binding properties on their respective receptors. The appearance of these two isoforms is the result of a small number of singlenucleotide substitutions in the two genes coding for the ot chains of FcyRIIIA and Fc~/RIIIB (9). Remarkably, despite extensive sequence identity extending into flanking sequences and introns, Fc~/RIIIA is expressed on NK cells and macrophages, where it mediates antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis, whereas Fc~/RIIIB is uniquely expressed on neutrophils, where it functions primarily as a sink for immune complexes and cannot mediate an activation signal in isolation (10) .
As a first step toward understanding the molecular basis for the differential expression of human Fc~tRIII genes, we have generated transgenic mice expressing human Fc~/RIIIA and Fc~/RIIIB using the intact genomic clones. In addition, promoter swap transgenics were generated in which the putative regulatory sequences have been exchanged: sequences derived from the FcyRIIIA gene 5' flanking region and first intron have been ligated in place of the corresponding sequences of the FcyRIIIB gene, and conversely, the analogous regions of Fc'yRIIIA have been substituted for similar sequences of the Fc~/RIIIB gene. Comparison of the Fc~/RIII expression on NK cells, macrophages, and neutrophils among these four transgenic lines shows that the cis elements conferring the cell-specific expression of the human FcyKIII locate on the 5' flanking sequence and first intron of these genes.
Materials and Methods
Transgene Constructs. Genomic clones encoding human FcT-RIIIA and Fc~/KIIIB (c9158 and c7733, respectively) were isolated as previously described (9, 11) . The NotI-SalI restriction fragment containing 5.8 kb of the 5' flanking sequence of the Fc'),RIIIA gene including the signal sequence and EC1 exons and the 13-kb SalI-NotI restriction fragment containing the EC2, transmembrane/cytoplasmic (TM/CYT), and 3' UT sequences of the FcTIIIB gene were isolated by gel purification, ligated, and cloned into the NotI site of cosmid vector pWE15. This yielded promoter swap construct PS19. Similarly, promoter swap construct PS28 was obtained by ligating three DNA fragments: the 19.2-kb NotI-SalI restriction fragment of IIIB including the 5' flanking sequences, the 5.8-kb SalI-EcoRI fragment from IIIA containing EC1, EC2, TM/CYT, and 3' UT exons, and the 5-kb EcoRI-NotI of IIIB containing the 3' flanking sequences (see Fig. 1 ).
Preparation of DNA Fragments for Microinjection. Large-scale plasmid preparations of transgene constructs were performed according to Sambrook et al. (12) . All four constructs were digested with NotI to release the inserts from vector sequences. Digests were fractionated by electrophoresis through 1% agarose gel. The inserts were isolated by excision of a gel slice and electroelution of the DNA fragment into 0.5• Tris-borate-EDTA buffer, followed by CsC1 density gradient centrifugation and ethanol precipitation. DNA pellets were washed in 70% ethanol, resuspended in deionized H20, and diluted to a concentration of 1-2 Ixg/ml with 1 • injection buffer (13) .
Transgenic Mice. The transgene constructs were microinjected into fertilized eggs from (C57B1/6 • CBA/CA) fl matings, and the injected eggs were transferred to pseudopregnant female CD-1 mice (Charles River Laboratories, Wilmington, MA) for development to term. Transgenic founders were identified by Southern blot hybridization of BamHI-digested tail DNA to a 32p-labeled annealed oligo spanning the transmembrane and cytoplasmic domain (nucleotides 642-732), which is conserved between IIIA and IIIB.
Flow Cytometry Analysis. Single-cell suspensions from bone marrow, spleen, and peritoneal cavity were prepared as described below. Aliquots of 106 cells were stained for 30 rain at 4~ in a 100-p.1 vol with combination of the following antibodies (1 p.g/ ml): FITC-anti-human CD16 (3G8 F(ab2)'; Medarex, Inc., West Lebanon, NH); PE-anti-mouse granulocyte (RJ36-8C1; PharMingen, San Diego, CA), and anti-mouse Mac-1 (M1/70; Boehringer Mannhein Corp., Indianapolis, IN). Cells were washed twice in PBS containing 1% BSA after each incubation and fixed in PBS and 1% formaldehyde. Fluorescence intensity was measured using a FACScan | (Becton Dickinson & Co., Mountain View, CA). Dead cells were eliminated from the analysis on the basis of forward and sideways light scatter.
Cell Preparation. Mice were injected intraperitoneally with 1 ml of 5% thioglycollate, and peritoneal cells were harvested 3 d later. The cells were suspended in RPMI 1640 supplemented with 10% heat-inactivated FCS and plated in 100 • 15-mm dishes (Falcon Labware, Becton, Dickinson & Co., Oxnard, CA) and incubated for 6 h at 37~ in 95% air, 5% CO2. Nonadherent cells were removed by rinsing the monolayers with PBS, and the purified macrophages were subjected to the flow cytometry analysis.
Bone marrow cells were flushed out of the femurs of mice using a 23-gauge needle, resuspended, and then washed in PBS. The erythrocytes were lysed by NH4C1 buffer (160 mM NH4CI , 17 mM Tris-C1, pH 7.4), and the remaining cells were centrifuged and washed with PBS. The bone marrow-derived neutrophils were then used for the FACS | analysis.
NK cells were prepared as described previously (14) . Briefly, spleens were removed aseptically, crushed, and resuspended in NK medium consisting of RPMI 1640 supplemented with 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 50 M 2-ME, 100 U/rni penicillin, 100 I~g/ml streptomycin, 2 mM glutamine, and 10% heat-inactivated FCS (HyClone Laboratories, Logan, UT). The erythrocytes were lysed by NH4C1 buffer, and the remaining cells were centrifuged and then passed through a nylon wool column. The nylon-passed cells were resuspended at 5 • 
Results and Discussion

Design of Promoter Swap Transgenic Constructs.
To determine which sequences are responsible for the cell type--specific expression of human FcTRIII, two promoter swap constructs were generated. As shown in Fig. 1 IIIB 5' flanking sequence of the NotI-SalI fragment to the IliA SalI-NotI fragment was not successful, since the resulting insert could not be stably propagated in Escherichia coli. W e therefore generated the PS28 construct by ligating three D N A fragments, creating a mosaic gene that contained the IIIB 5 ' flanking sequences, the IliA coding regions, and IIIB 3 ' untranslated regions. These two promoter swap constructs were confirmed by TaqI digestion and hybridization with exon-specific probes for the signal sequence and 3 ' UT, which distinguish between the IliA and IlIB sequences, as previously described (9 and data not shown). examined by FACS | analysis. Thioglycollate-elicited peritoneal macrophages were stained with a panel of macrophage makers, including Mac-1 and F4/80, and were counterstained with mAb 3G8, which detects both of the human Fo/I<III genes ix chains but not the endogenous mouse FcyP, III ix chain. As seen in Fig. 3 , macrophages derived from the IIIA-transgenic mice were positive for both Mac-1 and 3G8. Similar results were obtained using F4/80 (data not shown). PS19-transgenic mice that carry the 5' flanking sequences and first intron of the IliA gene similarly expressed a double-positive population of Mac-l/ 3G8 macrophages. In contrast, macrophages isolated from either IIIB-or PS28-transgenic mice were not stained with 3G8, yet retained their Mac-1 staining.
Bone marrow-derived neutrophils were characterized by flow cytometry using 3G8 and a granulocyte marker, Gr-1. As shown in Fig. 4 , neutrophils from IIIB-and PS28-transgenic mice were positive for both 3G8 and Gr-1, whereas the macrophages from these mice were negative for 3G8. In contrast, neutrophils from IliA-and PS19-transgenic mice as well as nontransgenic littermates were not stained with 3G8, yet were positive for the marker Gr-1. Macrophages from nontransgenic littermates of all lines showed no detectable 3G8 staining (data not shown).
Similarly, NK cells prepared from IL-2-activated splenocytes were positive for 3G8 staining on NK cells derived from IliA-and PS19-transgenic mice, as shown in Fig. 5 . 3G8 staining was not detected on splenic T or B cells. No detectable 3G8 staining was found on NK cells from IIIBand PS28-transgenic mice. These studies localized the macrophage/NK cell restricting element to a 5.8-kb fragment of the IliA gene and a neutrophil-specific element to a 19-kb region included in the 5' flanking sequences of the IIIB gene. Thus, despite the fact that the mouse expresses a single Fc~/P, III gene in neutrophils, macrophages, and NK cells, routine cells retained the ability to distinguish between these human sequences that drive cell type specificity.
Functional studies have suggested that IliA delivers an activation signal upon cross-linking by intmune complexes, whereas IlIB occupancy does not result in cellular activation in the absence of a costimulatory signal from another Fc receptor. Preliminary studies using these transgenic mice has confirmed these in vitro observations (Weiner, A., unpublished observations) and will allow for a detailed examination of the role oflIIB in vivo. Finally, the identification ofa neutrophil-specific DNA element will facilitate the targetting of gene expression to this important effector cell population and clarify the role of these cells in the inflammatory response. This study was supported by a grant from the National Institutes of Health and the DeWitt Wallace Foundation.
